A study spanning 20 years helps nail down the timing of biomarker changes that occur in the period between normal cognition and a diagnosis of sporadic Alzheimer's disease (AD), something that hasn't ...
PLYMOUTH MEETING, Pa., March 29, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results